160 related articles for article (PubMed ID: 8103069)
1. The role of CD4+ T cells in immunity to malaria sporozoites.
Weiss WR; Sedegah M; Berzofsky JA; Hoffman SL
J Immunol; 1993 Sep; 151(5):2690-8. PubMed ID: 8103069
[TBL] [Abstract][Full Text] [Related]
2. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
3. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
Doolan DL; Hoffman SL
J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein.
Takita-Sonoda Y; Tsuji M; Kamboj K; Nussenzweig RS; Clavijo P; Zavala F
Exp Parasitol; 1996 Nov; 84(2):223-30. PubMed ID: 8932772
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells.
Lucas B; Engel A; Camus D; Haque A
Cell Immunol; 1993 Aug; 150(1):59-71. PubMed ID: 8102089
[TBL] [Abstract][Full Text] [Related]
6. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
7. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages.
Carvalho LH; Sano G; Hafalla JC; Morrot A; Curotto de Lafaille MA; Zavala F
Nat Med; 2002 Feb; 8(2):166-70. PubMed ID: 11821901
[TBL] [Abstract][Full Text] [Related]
8. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells can initiate protective immune responses against malaria.
Bruña-Romero O; Rodriguez A
Infect Immun; 2001 Aug; 69(8):5173-6. PubMed ID: 11447201
[TBL] [Abstract][Full Text] [Related]
10. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
[TBL] [Abstract][Full Text] [Related]
11. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
[TBL] [Abstract][Full Text] [Related]
12. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria.
Vinetz JM; Kumar S; Good MF; Fowlkes BJ; Berzofsky JA; Miller LH
J Immunol; 1990 Feb; 144(3):1069-74. PubMed ID: 1967271
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
Charoenvit Y; Mellouk S; Cole C; Bechara R; Leef MF; Sedegah M; Yuan LF; Robey FA; Beaudoin RL; Hoffman SL
J Immunol; 1991 Feb; 146(3):1020-5. PubMed ID: 1988490
[TBL] [Abstract][Full Text] [Related]
15. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
16. Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development.
Kumar S; Good MF; Dontfraid F; Vinetz JM; Miller LH
J Immunol; 1989 Sep; 143(6):2017-23. PubMed ID: 2570802
[TBL] [Abstract][Full Text] [Related]
17. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.
Daly TM; Long CA
J Immunol; 1995 Jul; 155(1):236-43. PubMed ID: 7602100
[TBL] [Abstract][Full Text] [Related]
18. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
19. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
Meraldi V; Romero JF; Kensil C; Corradin G
Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
[TBL] [Abstract][Full Text] [Related]
20. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.
Weiss WR; Ishii KJ; Hedstrom RC; Sedegah M; Ichino M; Barnhart K; Klinman DM; Hoffman SL
J Immunol; 1998 Sep; 161(5):2325-32. PubMed ID: 9725227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]